No insider purchase over the last 90 days. The latest was filed 30 May 2024.
Every trade that managers of American Oncology Network, Inc. disclose to SEC (Form 4) is tracked on this page. No insider at American Oncology Network, Inc. has published a filing in the past twelve months. The most recent one dates from 18 July 2024.
Elsewhere in the same market, our signals recently picked up insider purchases at Relmada Therapeutics, Inc. and Uber Technologies, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
20 of 20 declarations
American Oncology Network, Inc. is a company specializing in the provision of oncology care services. It primarily operates in the United States and focuses on improving outcomes for cancer patients.